Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Bone Marrow Transplantation, Published online: 13 April 2024; doi:10.1038/s41409-024-02284-5Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Source: Bone Marrow Transplantation - April 13, 2024 Category: Hematology Authors: Arnon Nagler Myriam Labopin Ryszard Swoboda Thomas Schroeder Rose-Marie Hamladji Laimonas Griskevicius Urpu Salmenniemi Alessandro Rambaldi Stephan Mielke Alexander Kulagin Jakob Passweg Thomas Luft Tobias Gedde-Dahl Edouard Forcade Grzegorz Helbig Matthi Source Type: research